Michael Rosenberg is an associate in Goodwin’s Business Law Department and a member of its Technology and Life Sciences Groups. Mr. Rosenberg represents publicly and privately held corporations, investment banks, and venture capital firms focused on a variety of growth sectors. He represents clients in corporate finance transactions, mergers and acquisitions, joint ventures, licensing and strategic collaborations.

Mr. Rosenberg regularly advises both domestic and foreign issuers and investment banks in public and private offerings of equity and debt, including initial public offerings (IPOs), secondary offerings, confidentially marketed public offerings (CMPOs), at-the-market (ATM) financings, 144A offerings, registered direct offerings, and PIPEs, as well as seed financings and later-stage venture capital financings.

Mr. Rosenberg also advises corporate clients on a broad range of securities law and corporate governance matters, Securities and Exchange Commission (SEC) compliance, as well as domestic, cross-border, private and public mergers and acquisitions.

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Prior to joining Goodwin, Mr. Rosenberg was an associate at the New York Offices of three international law firms.

Mr. Rosenberg has advised on a number of deals in the public and private sectors, including:

  • Forward Pharma A/S’s IPO on Nasdaq in the U.S., which won M&A Advisor’s “Healthcare/Life Sciences Sector Deal of the Year” award*
  • AM-Pharma’s sale of a minority interest in the company to Pfizer Inc. and related option payment, which was a finalist for the 2015 Scrip Awards*
  • Zealand Pharma’s IPO on Nasdaq in the U.S*
  • Edge Therapeutics’ IPO on Nasdaq in the U.S.*
  • Iconix Brand Group, Inc.’s offering of High Yield Convertible Notes*
  • Griffon Corporation’s 144A Offering of High Yield Debt Securities*
  • U.S. Shale Solutions, Inc. in the 144A offering in Senior Secured Notes.* 
  • Dava Pharmaceuticals in its sale to Endo Pharmaceuticals.* 

* Denotes experience prior to joining Goodwin.

Professional Experience

Mr. Rosenberg was a member of the Fordham Moot Court and the Fordham Journal of Corporate and Financial Law.

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2009
Fordham University School of Law
B.A., 2006
Yeshiva University
(magna cum laude)

Admissions

Bar

New Jersey
New York
Get In Touch
German Translation
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师